QUANTIB® Prostate

Quantib

The artificial intelligence-based software, Quantib® Prostate, provides a workflow for detection of abnormalities on MRI prostate scans.
Product specifications Information source: Vendor
Last updated: March 25, 2021
General
Product name QUANTIB® Prostate
Company Quantib
Subspeciality Abdomen
Modality MR
Disease targeted Prostate cancer
Key-features prostate volume measurements, PSA density calculation, AI-supported ROI segmentation, PI-RADS v.2.1 scoring support, structured report
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion
Data characteristics
Population Prostate MRI scans with suspicion of prostate cancer
Input MRI, T2, DWI, DCE (optional)
Input format DICOM
Output Segmentation overlays, segmentation series, a structured report with key images and PI-RADS
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS), DICOM-based integration via own zero footprint AI platform
Deployment Locally on dedicated hardware, Cloud-based
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes
Certification
CE
Certified, Class IIb , MDR
FDA
510(k) cleared, Class II
Market presence
On market since 10-2020
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers